Cardiol Therapeutics Inc. (CRDL)
NASDAQ: CRDL
· Real-Time Price · USD
1.09
0.00 (0.00%)
At close: Sep 03, 2025, 3:59 PM
0.00% (1D)
| Bid | 1.09 |
| Market Cap | 90.5M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -37.55M |
| EPS (ttm) | -0.35 |
| PE Ratio (ttm) | -3.13 |
| Forward PE | -2.75 |
| Analyst | Buy |
| Ask | 1.1 |
| Volume | 40,981 |
| Avg. Volume (20D) | 691,414 |
| Open | 1.08 |
| Previous Close | 1.09 |
| Day's Range | 1.08 - 1.10 |
| 52-Week Range | 0.77 - 2.63 |
| Beta | 0.79 |
About CRDL
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol CRDL
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for CRDL stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts1 month ago
+14.75%
Cardiol Therapeutics shares are trading higher aft...
Unlock content with
Pro Subscription
11 months ago
-6.63%
Cardiol Therapeutics shares are trading lower after the company announced a $13.5 million public offering of 8,437,500 common shares priced at $1.60 per unit.
